48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Significant advances have been made uncovering the factors that render neurons vulnerable in Parkinson's disease (PD). However, the critical pathogenic events leading to cell loss remain poorly understood, complicating the development of disease-modifying interventions. Given that the cardinal motor symptoms and pathology of PD involve the loss of dopamine (DA) neurons of the substantia nigra pars compacta (SNc), a majority of the work in the PD field has focused on this specific neuronal population. PD however, is not a disease of DA neurons exclusively: pathology, most notably in the form of Lewy bodies and neurites, has been reported in multiple regions of the central and peripheral nervous system, including for example the locus coeruleus, the dorsal raphe nucleus and the dorsal motor nucleus of the vagus. Cell and/or terminal loss of these additional nuclei is likely to contribute to some of the other symptoms of PD and, most notably to the non-motor features. However, exactly which regions show actual, well-documented, cell loss is presently unclear. In this review we will first examine the strength of the evidence describing the regions of cell loss in idiopathic PD, as well as the order in which this loss occurs. Secondly, we will discuss the neurochemical, morphological and physiological characteristics that render SNc DA neurons vulnerable, and will examine the evidence for these characteristics being shared across PD-affected neuronal populations. The insights raised by focusing on the underpinnings of the selective vulnerability of neurons in PD might be helpful to facilitate the development of new disease-modifying strategies and improve animal models of the disease.

          Related collections

          Most cited references147

          • Record: found
          • Abstract: found
          • Article: not found

          Stages in the development of Parkinson's disease-related pathology.

          The synucleinopathy, idiopathic Parkinson's disease, is a multisystem disorder that involves only a few predisposed nerve cell types in specific regions of the human nervous system. The intracerebral formation of abnormal proteinaceous Lewy bodies and Lewy neurites begins at defined induction sites and advances in a topographically predictable sequence. As the disease progresses, components of the autonomic, limbic, and somatomotor systems become particularly badly damaged. During presymptomatic stages 1-2, inclusion body pathology is confined to the medulla oblongata/pontine tegmentum and olfactory bulb/anterior olfactory nucleus. In stages 3-4, the substantia nigra and other nuclear grays of the midbrain and forebrain become the focus of initially slight and, then, severe pathological changes. At this point, most individuals probably cross the threshold to the symptomatic phase of the illness. In the end-stages 5-6, the process enters the mature neocortex, and the disease manifests itself in all of its clinical dimensions.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The role of protein clearance mechanisms in organismal ageing and age-related diseases.

              The ability to maintain a functional proteome, or proteostasis, declines during the ageing process. Damaged and misfolded proteins accumulate with age, impairing cell function and tissue homeostasis. The accumulation of damaged proteins contributes to multiple age-related diseases such as Alzheimer's, Parkinson's or Huntington's disease. Damaged proteins are degraded by the ubiquitin-proteasome system or through autophagy-lysosome, key components of the proteostasis network. Modulation of either proteasome activity or autophagic-lysosomal potential extends lifespan and protects organisms from symptoms associated with proteostasis disorders, suggesting that protein clearance mechanisms are directly linked to ageing and age-associated diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Neurol
                Front Neurol
                Front. Neurol.
                Frontiers in Neurology
                Frontiers Media S.A.
                1664-2295
                19 June 2018
                2018
                : 9
                : 455
                Affiliations
                CNS Research Group, Department of Pharmacology and Physiology, Department of Neurosciences, Faculty of Medicine, Université de Montréal , Montreal, QC, Canada
                Author notes

                Edited by: Graziella Madeo, National Institutes of Health (NIH), United States

                Reviewed by: Paolo Gubellini, Centre National de la Recherche Scientifique (CNRS), France; Nicolas Xavier Tritsch, Langone Medical Center, New York University, United States

                *Correspondence: Louis-Eric Trudeau louis-eric.trudeau@ 123456umontreal.ca

                This article was submitted to Movement Disorders, a section of the journal Frontiers in Neurology

                †Co-first authors.

                Article
                10.3389/fneur.2018.00455
                6018545
                29971039
                bc37da4f-2298-4b9c-9be9-a89929681ad6
                Copyright © 2018 Giguère, Burke Nanni and Trudeau.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 05 April 2018
                : 29 May 2018
                Page count
                Figures: 1, Tables: 1, Equations: 0, References: 203, Pages: 20, Words: 14347
                Funding
                Funded by: Fondation Brain Canada 10.13039/100009408
                Funded by: Canadian Institutes of Health Research 10.13039/501100000024
                Award ID: 106556
                Funded by: Krembil Foundation 10.13039/501100004089
                Categories
                Neurology
                Review

                Neurology
                parkinson,vulnerability,dopamine,cell death,neurodegeneration
                Neurology
                parkinson, vulnerability, dopamine, cell death, neurodegeneration

                Comments

                Comment on this article